Structure Therapeutics, Inc. (GPCR)
53.48
+3.31
(+6.60%)
USD |
NASDAQ |
Apr 02, 16:00
53.43
-0.05
(-0.09%)
After-Hours: 20:00
Structure Therapeutics EPS Diluted (Quarterly) : 0.56 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Eli Lilly & Co. | 7.024 |
| Viking Therapeutics, Inc. | -1.383 |
| Revolution Medicines, Inc. | -1.855 |
| Novo Nordisk A/S | 0.9419 |
| Kymera Therapeutics, Inc. | -0.9674 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 33.15M |
| Total Expenses (Quarterly) | -33.15M |
| Enterprise Value | 2.349B |
| Earnings Yield | -4.60% |
| Normalized Earnings Yield | -4.824 |